Apolipoprotein E mimetic peptide, CN‐105, improves outcomes in ischemic stroke

OBJECTIVE: At present, the absence of a pharmacological neuroprotectant represents an important unmet clinical need in the treatment of ischemic and traumatic brain injury. Recent evidence suggests that administration of apolipoprotein E mimetic therapies represent a viable therapeutic strategy in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Tian Ming, Kolls, Brad J., Soderblom, Erik J., Cantillana, Viviana, Ferrell, Paul Durham, Moseley, M. Arthur, Wang, Haichen, Dawson, Hana N., Laskowitz, Daniel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376751/
https://www.ncbi.nlm.nih.gov/pubmed/28382306
http://dx.doi.org/10.1002/acn3.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376751/
https://www.ncbi.nlm.nih.gov/pubmed/28382306
http://dx.doi.org/10.1002/acn3.399

Ejemplares similares